top of page

Latest News

GLC Medical Inc. to Present at Global Conference

Oct 12, 2023

GLC Medical Inc. to Present at Global Conference

GLC Medical Inc. to Present at the 15th Annual Health & Humanitarian Conference

GLC Medical International BV (Belgium) Appoints Managing Director

Jul 13, 2023

GLC Medical International BV (Belgium) Appoints Managing Director

Belgium, July 13, 2023 – GLC Medical International BV (GLCMI) is pleased to announce the appointment of Frank Van Gelder as Managing Director to drive Growth and Innovation in medical Diagnostics. With over three decades of experience in the healthcare sector, Mr. Van Gelder brings a wealth of knowledge and expertise to his new role.

GLC Medical(GLCM) Inc. Incorporates new Company in Belgium

Jul 13, 2023

GLC Medical(GLCM) Inc. Incorporates new Company in Belgium

Edmonton, AB, July 13, 2023 – GLC Medical (GLCM) Inc., a dynamic and innovative Canadian diagnostic company, announces its official incorporation and entry into the Belgian and European healthcare market to advance its GLCM platform technology. With a strong focus on advanced diagnostics and improving health outcomes, GLC Medical International BV (GLCMI) aims to revolutionize medical diagnostics through cutting-edge technology and scientific expertise.

Successful Collaboration Between GLCM, the University of Sherbrooke, and Sherbrooke Hospital

May 4, 2023

Successful Collaboration Between GLCM, the University of Sherbrooke, and Sherbrooke Hospital

Validation in Quebec for GLCM's COVID-19 testing technology

GLC Medical Inc. Signs Memorandum of Understanding with UAE Company

Feb 14, 2023

GLC Medical Inc. Signs Memorandum of Understanding with UAE Company

GLC Medical (GLCM) Inc. is pleased to announce the signing of a Memorandum
of Understanding (MoU) with a very significant UAE company with the intent to advance the GLCM Biosensor Platform to commercialization.

Medical Diagnostic Breakthrough

May 11, 2022

Medical Diagnostic Breakthrough

Completion of the development of its GLCM Biosensor Test Platform

New technology developed in Edmonton to make taking a rapid test for COVID-19 easier

May 10, 2022

New technology developed in Edmonton to make taking a rapid test for COVID-19 easier

May be used to detect other diseases

GLCM Creates Solution for COVID-19 Testing - Discussion with Mark Connolly and Tara McCarthy

Mar 15, 2021

GLCM Creates Solution for COVID-19 Testing - Discussion with Mark Connolly and Tara McCarthy

Donna Mandau, President and CEO of Graphene Leaders Canada Inc., was invited to speak with Mark Connolly and Tara McCarthy on CBC Radio.

GLCM Prepares for Clinical Trials with Instant Covid-19 Test

Mar 13, 2021

GLCM Prepares for Clinical Trials with Instant Covid-19 Test

An Edmonton company is gearing up to offer what it believes is the world’s fastest COVID-19 detection test, which would also eliminate the need for a nasal swab.

GLCM Prepares to Offer What May be the World's Fastest COVID-19 Test

Mar 6, 2021

GLCM Prepares to Offer What May be the World's Fastest COVID-19 Test

Donna Mandau, President and CEO of Graphene Leaders Canada Inc. and J'lyn Nye discuss the development of GLCM’s SARS-CoV-2 Insta-Test. 

GLCM Announce World's Fastest COVID-19 Virus Detection Insta-Test

Mar 2, 2021

GLCM Announce World's Fastest COVID-19 Virus Detection Insta-Test

GLC Medical (GLCM) Inc. is pleased to announce completion of development of the GLCM SARS-CoV-2 Insta-Test, delivering results in under 15 seconds, offering the world the fastest, easiest to use and most cost-effective solution to screen for COVID-19.

New Rapid COVID-19 test taking off at EIA

Sept 25, 2020

New Rapid COVID-19 test taking off at EIA

Edmonton International Airport has been chosen as the exclusive location to trial a new COVID-19 test that can produce results in seconds.

GLCM Announce Rapid Detection COVID-19 Test – Results in Seconds

Jul 30, 2020

GLCM Announce Rapid Detection COVID-19 Test – Results in Seconds

Graphene Leaders Canada (GLC) Inc. together with subsidiary GLC Medical (GLCM) Inc. announce their development of a graphene-enhanced sensor for use in their COVID-19 Rapid Test delivering accurate and reliable results in seconds.

Looking for More?

We are expanding the global economy. The GLCM Biosensor Platform technology is available to license and will be a monumental product for future generations.


Modular integrations allow our technology to communicate with microelectronics. This can be utilized for real-time updates and relaying data to human resource managers and health associations.


GLC Medical is currently seeking strategic partners and welcomes all inquiries and discussions relating to the advancement of this breakthrough detection technology.


For more information, please email us at glcmsolutions@glcplus.com

bottom of page